MedPath

MS Versus NICE for Colorectal Lesions

Not Applicable
Completed
Conditions
Colorectal Polyp
Colorectal Neoplasms
Interventions
Other: Modified Sano's classification
Other: NICE classification
Registration Number
NCT02963207
Lead Sponsor
Lyell McEwin Hospital
Brief Summary

OBJECTIVE: Our study aimed to compare a recently-developed endoscopic classification with an established one for colorectal lesions in a randomised trial between 2013 and 2015.

Detailed Description

OBJECTIVE: Current practice requires histopathological assessment to confirm diagnosis for colorectal lesions detected at colonoscopy. Advances in endoscopic imaging contribute for real-time diagnosis which, apart from being cost and time-saving, also guides decision-making and reduces risks. Our study aimed to compare a recently-developed endoscopic classification with an established one.

DESIGN: The modified Sano's classification (MS) was compared to the Narrow Band Imaging (NBI) International Colorectal Endoscopic classification (NICE) in a randomised trial between 2013 and 2015. An experimented endoscopist classified each polyp, what was compared to histopathology.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
348
Inclusion Criteria
  • Patients admitted in the Endoscopy Unit for a colonoscopy
  • Patients over 18 years-old
  • Patients or their caregivers that have understanding of the procedure and that have signed the consent form for the study
Exclusion Criteria
  • Patients without colorectal polyps
  • Patients with poor bowel preparation
  • Patients that do not agree with or withdraw the consent form

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Modified Sano's ClassificationModified Sano's classificationModified Sano's Classification as described by Singh et al. 2013
NICE classificationNICE classificationNBI International Colorectal Endoscopic Classification as described by Hewett et al. 2012
Primary Outcome Measures
NameTimeMethod
Accuracy measures in comparison to the final histopathology in regards to polyps' invasivenessAfter two weeks of the colonoscopy

Comparison of NICE or MS with the final histopathology in regards to invasiveness (SSA/P, AP, TSA or superficial cancer versus invasive cancer)

Accuracy measures in comparison to the final histopathology in regards to polyps' subtype (neoplastic versus non-neoplastic)After two weeks of the colonoscopy

Comparison of NICE or MS with the final histopathology in regards to polyps' subtype (i.e. non-neoplastic = Hyperplastic Polyp (HP) and neoplastic = Sessile Serrated Adenoma/Polyp (SSA/P), Adenomatous Polyp (AP), Traditional Serrated Adenoma (TSA), superficial cancer and invasive cancer)

Accuracy measures in comparison to the final histopathology in regards to polyps' subtype (SSA/P versus non-SSA/P)After two weeks of the colonoscopy

Comparison of MS with the final histopathology in regards to SSA/P (SSA/P versus non-SSA/P)

Secondary Outcome Measures
NameTimeMethod
Accuracy in regards to negative predictive value of diminutive distal colorectal polypsAfter two weeks of the colonoscopy

Comparison of NICE or MS with the final histopathology in regards to \<5 mm distal to the sigmoid polyps (NPV for HPs - according to the PIVI guidelines)

Agreement in predicting post-colonoscopy surveillance interval with final histopathologyImmediately after the colonoscopy (endoscopic) and 2 weeks after (histopathology)

Comparison of NICE or MS with the final histopathology in regards to prediction of surveillance interval (according to the PIVI guidelines)

© Copyright 2025. All Rights Reserved by MedPath